Assessment of the feasibility of high-concentration capsaicin patches in the pain unit of a tertiary hospital for a population of mixed refractory peripheral neuropathic pain syndromes in Non-diabetic patients

Table 2 Health state evolution based on EuroQol-5D

	Health state (EuroQol-5D)
	Baseline		At 12 weeks	Difference
	Descriptive	VAS^a	VAS^a
Post-herpetic neuralgia	11121	60	75	+15
	22233	25	50	+25
	22232	50	40	−10
	11131	30	80	+50
	22232	25	40	+15
	12222	70	50	−20
Total knee arthroplasty post-surgical pain	22232	90	20	−70
	21121	50	60	+10
	22333	30	40	+10
Painful scar	22333	20	30	+10
	11132	90	90	0
	21333	35	20	+15
	22232	20	20	0
Femoral cutaneous neuropathy	11231	80	90	+10
Femoral cutaneous neuropathy	11232	50	80	+30
Neuroma	21222	70	80	+10
	12232	70	40	−30
	11231	50	100	+50
CRPS-I	11323	50	50	0
HIV-associated neuropathy	21221	50	70	+20

ISSN: 1471-2253